Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 268 results for "hetero drugs"

Hetero Drugs denies all CBI charges
Deccan Chronicle

Hetero Drugs denies all CBI charges

The special court for CBI cases here in Nampally on Thursday was hearing the discharge petition filed by the pharma company. (Photo: PTI) Hyderabad: The counsel for Hetero Drugs, an accused in YSRC chief Y.S. Jagan Mohan Reddy's quid pro quo ... Deccan Chronicle, 2 weeks ago

1 images for "hetero drugs"

Deccan Chronicle, 1 week ago

Hetero Group exits pharmacy retailing; Sales biz to Apollo Hospitals

The Hetero Group has decided to exit pharmacy retail business and focus on their core pharmacy and bulk drugs business by selling the assets of Hetero Med Solutions to Apollo Hospitals. The Chennai-headquartered Apollo Hospitals Enterprise Ltd ...
 Business Standard India2 months ago Apollo to acquire Hetero's stores  The Hindu2 months ago Apollo to acquire Hetero Med's retail pharmacy stores business for $24M  VC Circle2 months ago
Seeking Alpha

Gilead Sciences : HETERO DRUGS SIGNS UP WITH GILEAD

Gilead Sciences Inc , USA has given licensing rights to Hetero Drugs to manufacture and market Sofosbuvir and combination drug Ledipasvir/Sofosbuvir. As per an agreement signed by Hetero Drugs with Gilead, Hetero can market the ...
 4 Traders2 months ago Hetero Enters License Agreement With Gilead Sciences Inc., USA to Produce Generic Sofosbuvir for Treatment of Chronic Hepatitis C  4 Traders2 months ago Gilead: Rising Net Income, Zero Debt And Strong R&D Pipeline  Seeking Alpha2 days ago
[x]  
International Business Times India

Surround Sound: Apollo's Hetero deal raises some questions

Why would Apollo Hospitals want to acquire pharmacy stores in regions where it already has a strong presence? And what is its plan to turn around a chain that made losses in the last fiscal year? These are some questions analysts have been raising ...
 InToday1 month ago Apollo Hospitals Enterprise : TO BUY HETERO MED'S DRUG STORES FOR Rs146 CRORE  4 Traders2 months ago Apollo Hospitals to acquire 320 Hetero pharmacy stores at a cost of Rs.146 cr  PharmaBiz2 months ago Apollo to buy Hetero pharmacies  Deccan Chronicle2 months ago
[x]  
Business Standard

Gilead inks licensing pacts for Hep C drug with Ranbaxy, Cipla, Mylan, four Indian firms

Seven India-based firms - Ranbaxy, Cipla, Mylan, Cadila, Hetero, Sequent and Strides Arcolab - will produce hepatitis C medicines for distribution in 91 developing countries BS B2B Bureau | New Delhi September 17, 2014 Last Updated at 13:18 IST In what could ...
 Business Standard2 months ago Gilead signs licenses with generic drugmakers for hepatitis C drugs15-09-2014  Pharma Letter2 months ago Gilead announces generic licensing agreements with Indian companies  Manufacturing Chemist2 months ago Access to Hepatitis C Drugs to be Expanded in Developing World  MedIndia2 months ago
[x]  
Rediff.com

Pharma Cos face problems in distribution of drugs in J

HYDERABAD: Pharmaceutical companies, which are sending across medical aid for flood affected people in Jammu and Kashmir, claim to be facing difficulties in distribution of drugs. M Srinivas Reddy, Director (marketing) of Hetero Drugs Limited, a ...
 Indolink2 months ago Pharma Cos facing problems in distributing drugs in J&K: Executive  The Echo Of India2 months ago 'Pharma cos face probs in distribution of drugs in J-K'  Rediff.com2 months ago
Times of India

India may run out of free drug for HIV programme

NEW DELHI: India could run out of a critical medicine in its free HIV/AIDS drugs programme in three weeks due to bureaucratic bungling, a senior government official said, leaving more than 150,000 sufferers without life-saving drugs for about a ...
 Times of India1 month ago India set to run out of critical free drug for HIV/AIDS programme  IBNLive India News1 month ago Exclusive - India set to run out of critical free drug for HIV/AIDS programme  Yahoo! News1 month ago Exclusive: India set to run out of critical free drug for HIV/AIDS program  ACQ Magazine1 month ago
[x]  

Indian drug makers in UN patents pool

The UN-backed Medicines Patents Pool has signed six sub-licences with Aurobindo, Cipla, Desano, Emcure, Hetero Labs and Laurus Labs, allowing them to make generic anti-AIDS medicine Tenofovir Alafenamide (TAF) for 112 developing countries. TAF is ...
 Hindu Business Line1 month ago Medicines Patent Pool signs six new sub-licenses for HIV treatment tenofovir alafenamide  Pharma Letter1 month ago Medicines Patent Pool signs deal with 5 Indian companies for HIV drug  Business Standard1 month ago Cipla : INDIAN DRUG MAKERS IN UN PATENTS POOL  4 Traders1 month ago

No swine flu drugs in Hyderabad

Ayesha who has been diagnosed with swine flu is admitted at Aware Global Hospitals and her family has been running around searching for the medicine but none of the medical stores have it Hyderabad: Drugs like Fluvir and Tamiflu used to treat ...
 Deccan Chronicle1 month ago

Apollo in talks to buy Hetero: ET

Indian healthcare major Apollo Hospitals Enterprise is in advanced discussions to acquire Hyderabad-based retail pharmacy chain Hetero Pharmacy, the Economic Times (ET) said, citing two people with knowledge of the matter. If a deal is reached it ...
 M&A Portal2 months ago Apollo May Buy Pharmacy Retail Chain Hetero  Deal Curry2 months ago Apollo To Buy Pharmacy Retail Chain Hetero  Deal Curry2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less